DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20181650

Comparison of drug information in package inserts with standard medical textbook of pharmacology

Amit Jain, Amita Jindal, Nagma Bansal, Hobinder Arora

Abstract


Background: Accurate and reliable drug product information is important for the safe and effective use of medicines. But there are variations in the quantity and quality of information mentioned in different drug information sources and a single credible benchmark is lacking. This study was carried out to compare the presentation and completeness of clinical information in package inserts (PIs) marketed by pharmaceutical companies in India with standard medical textbook of pharmacology.

Methods: Out of eighty five PIs of different drugs, only 55 were found eligible to be included in this study after applying inclusion and exclusion criteria. These PIs and medical textbook were analysed for quantitative and qualitative drug information and were compared using Chi square test of two proportions. The p value of 0.05 was used as cut off to evaluate statistical significance.

Results: Quantitatively medical textbook was significantly better statistically in context of treatment of overdose and references. No statistically significant difference was observed in relation to information related to mechanism of action (MOA) and pharmacokinetics (Pk). After qualitative analysis, medical textbook was significantly better statistically in context of size and readability, references related to adverse drug reactions (ADRs) and indications and pictures. No statistically significant difference was observed in context of dosing interval, frequency of doses and pharmacokinetic parameters.

Conclusions: PIs can be used as a reliable source of drug information by health care professionals in addition to other sources like medical textbooks.


Keywords


Drug information sources, Package inserts, Standard medical textbook

Full Text:

PDF

References


Radley DC, Finkelstein SN, Stafford RS. Off -label prescribing among office-based physicians. Arch Intern Med. 2006;166:1021-6.

Ansani N, Branch R, Fedutes-Henderson B, Smitherman T, Weber RJ, Skledar S, et al. United States medical practice summary: Innovative off -label medication use. Am J Med Qual. 2006;21:246-54.

Rajan MS, Sreedhar, Khan SA, Thiyagu R, Rao PG. Information seeking behaviour of clinicians in a semi urban town in southern India. J Clin Diag Res. 2008;2:1069-73.

Ved JK. Package Inserts in India: Need for a Revision. Int J Pharm Sci Res. 2010;1(11):454-6.

Tayyem MM. Patient’s Safety Information Available On Drug Package Inserts Used In Neuroanesthesia. Int J Clin Anesthesiol. 2009;19(2).

Joubert PH, Skene D. Attitudes of private medical practitioners towards package inserts and other drug information sources. S Afr Med J. 1984;66:306-7.

Dikshit RK, Dikshit ND. What information is available on request from drug advertisers. BMJ. 1996;313:855-6.

Lal A, Sethi A. Drug package inserts in India. Ann Pharmacother. 1996;30:1041.

Govt. of India, Ministry of Health and Family Welfare. Drug and Cosmetics Rules; 1945:265. Available at: http://cdsco.nic.in/html/DrugsandCosmeticAct.pdf. [cited 2008 Nov 21].

Ramdas D, Chakraborty A, Swaroop HS, Faizen S, Kumar P, Srinivas BN. A study of package inserts in Southern India. J Clin Diagn Res. 2013;7(11):2475-7.

Shivkar YM. Clinical information in drug package inserts in India. Journal of Postgraduate Medicine. 2009;55(2):104-7.

Koneri R, Prakasam K, Mishra V, Rajan H. Drug-related hospitalizations at a tertiary level hospital in Bangalore: A prospective study. J Clin Diag Res. 2008;2:736-40.

Saha L, Pandhi P, Malhotra S, Sharma N. Adverse drug event (ADE) related medical emergency department visits and hospital admissions: A prospective study from a north Indian referral hospital. J Clin Diag Res. 2008;2:600-4.